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Introduction
It is well known that new blood vessel formation results from two basic processes, vasculogenesis and angiogenesis (1) (2) (3) (4) . The former is defined as a process whereby endothelial progenitor cells are incorporated into nascent vessels as they form the primary capillary plexus, and this process is restricted to embryogenesis. The term angiogenesis refers to the sprouting and branching of pre-existing vessels. While angiogenesis plays an important role in the embryo, it is the sole mechanism by which physiological and pathological vessel formation occurs in the adult. Examples of physiological angiogenesis include the formation of new blood vessels during the adult female reproductive cycles and in the context of would healing (1, 2) . Pathological angiogenesis in adult tissues is associated with a variety of diseases, including diabetic retinopathy, tumor growth, and inflammation. Angiogenesis is strictly regulated by proangiogenic and angiogenic inhibitory factors during embryogenesis as well as in the adult. Although many aspects of angiogenesis are conserved, there are clear differences in molecular pathways that regulate vessel development in different contexts. For instance, gene targeting experiments in mice have shown that certain molecules are critical for the development of specific vascular beds (5) . Also, there are unique genetic and physiological aspects of pathological angiogenesis in the adult (6) . Although a wealth of new information has become available in recent years regarding the molecular regulators of angiogenesis, much remains to be learned, especially with regard to pathological angiogenesis.
One complex group of molecules that are essential for all aspects of endothelial cell structure and morphogenesis, are those cell surface proteins found at the cell-cell junctions.
These molecules are organized in two primary structures, the adherens junctions and tight junctions. Both play critical roles in endothelial permeability and cell polarity. Multiple by guest on January 28, 2018 http://www.jbc.org/
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different protein types reside in these structures, and mediate physical adhesion, and are also well known to transmit signals to the cellular cytoskeleton and to the nucleus. VE-cadherin molecules are endothelial cell-specific and localized in adherens junctions, where they have been shown to interact with structural proteins and signaling molecules including catenins (7) .
Targeted disruption of VE-cadherin reveals an early embryonic role for this molecule in endothelial cell differentiation, endothelial cell organization into vessels, and angiogenesis (8) .
Endothelial specific molecules in the tight junctions include junctional adhesion molecule (JAM) family members. Platelet endothelial cell adhesion molecule (PECAM-1) or CD31 and melanoma cell adhesion mole (MCAM) or CD146/MUC18, are not restricted to one type of junctional structure and this broad localization appears to be important to their vascular functions.
PECAM-1 function has been linked to angiogenesis (9-11).
A novel endothelial-cell surface protein of the immunoglobulin-superfamily has been recently cloned in this laboratory, and named endothelial cell-selective adhesion molecule (ESAM) (12) . Previous studies have determined that ESAM expression is restricted to endothelial cells in the embryonic and adult vasculature (12, 13) . ESAM has been shown to mediate homophilic and calcium-independent adhesion of expressing cells (12) . These data suggest that ESAM has specific endothelial cell functions, and thus may play a role in maintaining vascular integrity or blood vessel formation. In order to gain better understanding of the angiogenic functions of ESAM in vivo, knockout mice functionally lacking ESAM have been generated. These mice have been evaluated with in vivo and in vitro models of angiogenesis. In vivo tumor growth in ESAM-knockout (ESAM-/-) mice was significantly retarded compared with that in wild-type (WT) mice. The reduced tumor volume in ESAMknockout mice was associated with less vascular density. We also documented that ESAM null by guest on http://www.jbc.org/
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Experimental Procedures
Genomic cloning and generation of ESAM deficient mice
This study was approved by the ethics board for experimental animals at Stanford University, and all animal preparations were performed within the Institutional Guidelines of Stanford University School of Medicine.
A mouse ESAM cDNA probe (EcoRI-SacI fragment) was employed for screening a lambdaphage 129/SvJ genomic library (Stratagene, La Jolla, CA), providing two overlapping clones 18kb and 13.5kb in size. These phage clones were restriction mapped, and the exon/intron structure was partially determined by mapping and nucleotide sequence analysis.
The replacement targeting vector was constructed in the pKO Scrambler NTKV-1901 vector (Stratagene, San Diego, CA) using a 3.4 kb ScaI-ScaI fragment for the 5' arm, and a 6.4 kb PstIPstI fragment for the 3' arm ( Figure 1A ). After homologous recombination, a 3' portion (from 20 bp upstream of the translation initiation codon) of exon I of ESAM was thus replaced by a β-galactosidase (lacZ) and neomycin phosphotransferase (neo) cassette. Also, a cassette for herpes simplex virus-thymidine kinase (TK) was provided outside the region of homology to allow negative selection.
TL-1 129 embryonic stem (ES) cells (Brigid Hogan, Vanderbilt University, Nashville, TN) were used for transfection for the targeting vector. Cell culture, transfection, positive-, and negative-selection were performed as described previously (14) . Genomic DNA was isolated by guest on http://www.jbc.org/
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Ishida et al, ESAM deficient mice and angiogenesis -page6 -from each clone, and evaluated by Southern blot with 5' and 3' probes outside the homology domains ( Figure 1A) . Three of the correctly targeted ES cell clones were injected into C57Bl/6 blastocysts to generate chimeric animals. Three chimeric male mice were obtained and bred to C57Bl/6 females (Jackson Labs, Bar Harbor, Maine) to obtain heterozygous pups. Male heterozygous mice (ESAM+/-) were bred to C57Bl/6 females five times before homozygous animals (ESAM-/-) were generated. Wild-type littermates (WT) served as controls for all lines studied. Genotyping of knockout animals was performed with DNA isolated from tail tissue which was digested with EcoRV, and separated on 0.65% agarose gels. After transfer to nylon membranes, blots were hybridized with radiolabeled probes synthesized utilizing 5'(XbaI-SalI) or 3' (PstI-EcoRV) fragments by random priming (Figure 1 ). Genotypes of mice were verified by detection of the fragments that differ in size between the wild type and the targeted locus.
For detection of ESAM expression in the mutants, total RNA was isolated from mouse tissues and northern blotting were performed as described previously (12) . A mouse ESAM (1.2 kb) cDNA was used as a probe.
Retinal fluorescein angiogram
Mice were anesthetized with pentobarbital, and a median laparotomy was performed. 
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Matrigel plug assay
This assay was performed as described previously (16) . Briefly, 500µl of Matrigel (Beckton Dickinson, San Jose, CA) containing 100 ng/ml basic fibroblast growth factor (bFGF) was injected subcutaneously into the frank of WT and ESAM-/-mice. Seven days later, Matrigel plugs were excised under anesthesia, weighed, and homogenized in the Drabkin's Reagent (Sigma, St. Louis, MO). After centrifugation, the supernatants were filtered through 0.45µm filters and hemoglobin content was measured at the wavelength of 540nm following the manufacturer's instruction.
In vitro two dimensional tube formation assay on Matrigel
Aortic endothelial cells were isolated from the thoracic aorta of WT and ESAM-/-mice by an explant method (17) . The cells were propagated in M199 medium, with 10% fetal bovine serum, 30 µg/ml endothelial cell growth supplement, 20 U/ml heparin, 2mM L-glutamine and penicillin/streptomycin. Cells were verified as endothelial by DiI-acetyl-LDL uptake prior to the assay. Third or forth passage cells were used for tube-forming assays. In vitro angiogenesis assays on Matrigel were conducted in 24-well plates coated with 100µl Matrigel (18) . The cells were plated at a density of 5x10 4 cells/well and tube formation was observed every 3 hours.
For a gain-of-function experiment with ESAM, an embryonic yolk sac cell line (Pro5) was engineered to express ESAM tagged with the FLAG-epitope at the C-terminus. The Pro5 cells were cultured in minimum essential alpha medium containing 20% FBS and 0.002% β-mercaptoethanol and used for transfection. An ESAM-pcDNA3 plasmid (12) 
Cell migration assay
Cell migration assays were performed using modified Boyden chambers (Corning Coaster)
containing polycarbonate membranes (19) . The bottom-side of the membrane of the upper chamber was coated with 10µg/ml collagen type I for 2 h at 37˚C, rinsed once with PBS, and then placed into the lower chamber containing 500µl migration buffer (DMEM with 0.5%BSA).
Endothelial cells from WT or ESAM-/-mice were removed from culture dishes with PBS containing 5mM EDTA, washed twice with migration buffer, and then resuspended in migration buffer at the density of 1x10 6 cells/mL. 20,000 cells were then added to the top chamber.
Migration buffer alone (negative control), 50 ng/ml bFGF, or 3% fetal bovine serum (positive control) in migration buffer was added to the bottom chamber to stimulate cell migration. Cells were incubated at 37˚C for 4 hours. Non-migratory cells on the upper membrane surface were removed with a cotton swab, and the migratory cells attached to the bottom surface of the membrane were stained with 0.1% crystal violet in 0.1M borate (pH 9.0) and 2% ethanol for 1 h at room temperature. The number of migratory cells per membrane was counted with an inverted microscope. Each neasurement was the average of three or four individual wells.
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Differences between groups were analyzed using one-way analysis of variance. Data are expressed as means±SE. When statistically significant differences were found (p<0.05), individual comparisons were made using the Bonferroni/Dann's test.
Results
Homologous recombination and production of ESAM-/-mice
Mapping and nucleotide sequence analysis revealed a 5' most exon that contained 5'-untranslated sequence, the initiating methionine of the murine ESAM gene, corresponding to published ESAM cDNA sequence. The organization of this exon (hereafter referred to as exon I, Figure 1A ) is similar to what is seen in the human ESAM locus. Exon I was targeted and replaced with the lacZ and neomycin resistance genes. Southern blot analysis was performed with both 5' and 3'probes to verify substitution of the targeted region by homologous recombination ( Figure 1B ). To demonstrate that the ESAM gene was inactivated in ESAM-/-mice, several tissue RNAs were prepared and analyzed by northern blotting using a mouse ESAM cDNA probe. As shown in Figure 1C , wild type mice expressed the largest amount of ESAM mRNA in lung, and then kidney and heart. Relatively lower expression was detected in the aorta, liver ( Figure 1C ), skin and eye (data not shown). ESAM-/-mice were deficient in this mRNA in these organs. ESAM-/-mice were viable and fertile and did not exhibit overt defects. There was a significant 15% decrease in body weight of ESAM-/-mice compared to WT mice. The body weights of male WT and ESAM-/-mice were 13.4±1.0g vs. 
Physiological vessel density was normal in ESAM-/-mice
It has been shown that ESAM is expressed in endothelial cells in a variety of organs including the skin and eye. To examine the vascular network in ESAM-/-mice, fluoresceine angiography was performed by injection of FITC-dextran in vivo ( Figure 2 ). Similar blood vessel density was observed between WT and ESAM-/-mice. There was no difference in the number of large vessels originating from the optic nerve head and small branching vessels were similar between WT and ESAM-/-mice. Similarly, there was no difference in the skin vessel character or density between WT and ESAM-/-mice (data not shown).
ESAM-/-mice showed decreased tumor growth and in vivo angiogenesis
It has been recognized that tumor growth is dependent on vascularization. To explore a role for ESAM in pathological angiogenesis, we employed an in vivo angiogenesis model using two different types of murine tumors, the B16F10 melanoma and LL/2 Lewis Lung carcinoma.
Representative sets of tumors in each group of mice at day 14 are shown ( Figure 3A and 3B, top panels). Solid tumors that developed after injecting tumor cells were smaller in the ESAM-/-mice compared to those in WT mice. The delayed tumor growth in ESAM-/-mice was observed at all time points until tumor excision was performed 14 days after injection ( Figure 3A and 3B, bottom panels). By 12 days after injection, the mean B16F10 tumor size was 48%
smaller in ESAM null mice than WT mice (p<0.01). The mean LL/2 tumor size was 37% 
ESAM-/-mice showed a decrease in neovascularization in Matrigel plugs
To explore the angiogenic potential of ESAM-/-mice, we implanted Matrigel plugs in the flank region of mice. In this model, the host endothelial cells migrate and form a capillary network in the Matrigel implants (16) . The degree of vessel formation within the implants can be quantified by measuring the hemoglobin content of the excised implants. At 7 days after implantation, Matrigel plugs excised from ESAM-/-mice showed a significant decrease in hemoglobin content compared with those from wild type mice, 53% of wild type levels (p<0.05, n=5, Figure 6 ). Therefore, ESAM-/-mice had less ability to vascularize the Matrigel plug.
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To address whether the decreased vascularization of Matrigel plugs and tumors in ESAM-/-mice was an autonomous defect of the endothelial cells, we isolated aortic endothelial cells from WT and ESAM-/-mice and compared their tube forming capacity in vitro. Cells were verified as endothelial by DiI-acetyl-LDL uptake ( Figure 7A ). These cells were plated on Matrigel and tube-like network formation was observed ( Figure 7B ). The endothelial cells displayed morphological changes such as elongation and alignment on Matrigel to form two-dimensional tube-like structures. However, this activity was markedly attenuated with ESAM-/-endothelial cells. The network formation of endothelial cells on the Matrigel was quantified by measuring the tube number. As depicted in Figure 7C , ESAM-/-endothelial cells showed a significant 32% decrease in the number of tubes compared to wild type mice (p<0.05, n=5). These finding suggest that ESAM-/-endothelial cells per se have less angiogenic potential.
ESAM expression promotes tube formation in yolk sac cells
To further explore the role of ESAM through in vitro studies, a gain-of-function experiment was performed using a yolk sac cell line that stably over-expressed ESAM. This yolk sac cell line was documented to express low levels of ESAM, and transfectants documented to express high 
ESAM null endothelial cells showed decreased migratory response to bFGF
To further characterize the angiogenic function of ESAM, in vitro migration assays were performed with endothelial cells isolated from WT and ESAM-/-mice. As shown in Figure 9 , a decrease (30%) in migration was observed with 50 ng/ml bFGF treated ESAM-/-cells compared to bFGF-treated WT cells, while equivalent migration was seen with serum-treated ESAM-/-and WT endothelial cells. These data suggest the ESAM may be important for endothelial cell migration under certain circumstances, especially when cells are exposed to bFGF.
Discussion
The normal development and reproduction of ESAM-/-mice argues that this molecule is not essential for vasculogenesis or embryonic angiogenesis, and the ability of the null animals to reproduce suggests that it is also not required for some forms of angiogenesis in the adult animal. Interestingly, although the absence of ESAM was associated with decreased vessels of all sizes in the tumors, the decrease in larger vessels rather than capillaries appeared more prominent.
The retarded tumor growth in ESAM-/-mice was likely attributable to less angiogenic activity of the endothelial cells, through loss of homophilic interactions. However, loss heterophilic interaction of ESAM with a tumor molecule might also be the mechanism of the observed slower tumor growth rate in knockout animals.
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suggesting that ESAM is a component of the tight junction complex in this cell type (13) . Tight junctions seal the intercellular space and regulate paracellular permeability across endothelial or epithelial cell layers. In addition to the mechanical adhesion properties of adhesion molecules, however, there is accumulating evidence that immunoglobulin superfamily adhesion molecules modulate angiogenic processes both in vitro and in vivo by activation of cytoplasmic signaling cascades, by interaction with cytoskeletal proteins, and by functional interaction with other types of cells such as bone marrow derived cells and tumor cells (8, 22) . It has been shown that ESAM has putative interaction domains, including an SH3 binding domain (12) and possibly a PDZ binding domain (13) . Further studies are required to address these issues.
ESAM is one of a number of immunoglobulin domain cell surface molecules that are specifically expressed in the endothelial cell, localize to the cell-cell junction, and may have overlapping functional roles. Members of the JAM family are most relevant, as they are also found to localize to the tight junction. This family of proteins includes JAM, which is expressed in endothelial cells and epithelial cells, JAM-2 (23,24), JAM-3 (25, 26) and VE-JAM (27) . It has been shown that JAM plays a role in paracellular permeability and leukocyte transmigration, but a potential role in angiogenesis has not been elucidated (28) . Although ESAM-/-mice revealed no differences in development of superficial radial or collateral vessels.
No differences in structure (tortuosity, vessel dilatation) between groups were observed, and no hemorrhages were present. showing that ESAM-/-tumors had a significant decrease in microvessel number, *p<0.05 vs.
WT. 
